相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type
Jae-Cheol Jo et al.
ANNALS OF HEMATOLOGY (2017)
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma
Yong Yang et al.
JAMA ONCOLOGY (2017)
Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis
Mehdi Hamadani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase
Yok-Lam Kwong et al.
BLOOD (2017)
EBV-negative Aggressive NK-cell Leukemia/Lymphoma Clinical, Pathologic, and Genetic Features
Alina Nicolae et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Five-year analysis from phase 2 trial of sandwich chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Li Zhang et al.
CANCER MEDICINE (2016)
Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites
Li-Min Gao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Complete remission of refractory disseminated NK/T cell lymphoma with brentuximab vedotin and bendamustine
Li-Mei Poon et al.
ANNALS OF HEMATOLOGY (2016)
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases
Jennifer A. Kanakry et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Javeed Iqbal et al.
BLOOD REVIEWS (2016)
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China
Xin Li et al.
CLINICAL CANCER RESEARCH (2016)
A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm
Umberto Falcone et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
Anamarija M. Perry et al.
HAEMATOLOGICA (2016)
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia
Ki Sun Jung et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
Xi-wen Bi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET ONCOLOGY (2016)
Sequential DICE combined with L-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma
Li-Hua Dong et al.
LEUKEMIA & LYMPHOMA (2016)
Diagnosis and management of extranodal NK/T cell lymphoma nasal type
Eric Tse et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
Anamarija M. Perry et al.
HAEMATOLOGICA (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma
Ho-Young Yhim et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Nasal NK/T-cell lymphoma: RT, CT, or both
Eric Tse et al.
BLOOD (2015)
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study
Yong Yang et al.
BLOOD (2015)
Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma
Yun-Wen Chen et al.
BLOOD (2015)
Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma
Can Kuecuek et al.
CLINICAL CANCER RESEARCH (2015)
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study
Hao Ding et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang et al.
NATURE GENETICS (2015)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Kucuk et al.
NATURE COMMUNICATIONS (2015)
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
Seungbok Lee et al.
ONCOTARGET (2015)
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET HAEMATOLOGY (2015)
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
Miso Kim et al.
ANNALS OF HEMATOLOGY (2015)
Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities
Wook Youn Kim et al.
LEUKEMIA & LYMPHOMA (2015)
Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
Hee Kyung Kim et al.
BLOOD RESEARCH (2015)
Primary Cutaneous NK/T-cell Lymphoma, Nasal Type and CD56-positive Peripheral T-cell Lymphoma
Katsuyoshi Takata et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Seok Jin Kim et al.
ANNALS OF HEMATOLOGY (2014)
Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group
E. Tse et al.
BONE MARROW TRANSPLANTATION (2014)
Midtreatment 18F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center
Pek-Lan Khong et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance
Y-L Kwong et al.
LEUKEMIA (2014)
Development of human natural killer cells and other innate lymphoid cells
Elisa Montaldo et al.
SEMINARS IN IMMUNOLOGY (2014)
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
Liang Wang et al.
CANCER (2013)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Benjamin J. Chen et al.
CLINICAL CANCER RESEARCH (2013)
Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
Hee Kyung Ahn et al.
INVESTIGATIONAL NEW DRUGS (2013)
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
Seok Jin Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Extranodal NK/T-cell Lymphoma, Nasal Type, Includes Cases of Natural Killer Cell and αβ, γδ, and αβ/γδ T-cell Origin: A Comprehensive Clinicopathologic and Phenotypic Study
Tawatchai Pongpruttipan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
Hiroshi Kimura et al.
BLOOD (2012)
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong et al.
BLOOD (2012)
Phase 2 trial of Sandwich L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
Ming Jiang et al.
CANCER (2012)
Practical management of natural killer/T-cell lymphoma
Eric Tse et al.
CURRENT OPINION IN ONCOLOGY (2012)
Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Janus Kinase 3-Activating Mutations Identified in Natural Killer/T-cell Lymphoma
Ghee Chong Koo et al.
CANCER DISCOVERY (2012)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Arnaud Jaccard et al.
BLOOD (2011)
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series
Adnan Mansoor et al.
BLOOD (2011)
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
Kennosuke Karube et al.
BLOOD (2011)
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I. Cohen et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
Siok-Bian Ng et al.
JOURNAL OF PATHOLOGY (2011)
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
J. Iqbal et al.
LEUKEMIA (2011)
PRDM1 is a tumor suppressor gene in natural killer cell malignancies
Can Kuecuek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
NK cell development, homeostasis and function: parallels with CD8+ T cells
Joseph C. Sun et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
Yenlin Huang et al.
BLOOD (2010)
Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation
Kengo Takeuchi et al.
BLOOD (2010)
Central palatal perforation in nasal natural killer cell lymphoma
Yok-Lam Kwong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas
Winnie K. S. Chan et al.
CLINICAL NUCLEAR MEDICINE (2010)
Non-nasal natural killer cell lymphoma: not non-nasal after all
Eric Tse et al.
ANNALS OF HEMATOLOGY (2009)
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008
J. I. Cohen et al.
ANNALS OF ONCOLOGY (2009)
High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies
Y. -L Kwong
BONE MARROW TRANSPLANTATION (2009)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Seok Jin Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies
Pek-Lan Khong et al.
ANNALS OF HEMATOLOGY (2008)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Selective apoptosis of natural killer-cell tumours by L-asparaginase
M Ando et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms
N Murashige et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement
CS Chim et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
MHC class I molecules and KIRs in human history, health and survival
P Parham
NATURE REVIEWS IMMUNOLOGY (2005)
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells
R Suzuki et al.
LEUKEMIA (2004)
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients
WY Au et al.
BLOOD (2004)
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
CS Chim et al.
BLOOD (2004)
Primary natural killer cell lymphoma of skeletal muscle
CS Chim et al.
HISTOPATHOLOGY (2002)
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection
H Kimura et al.
BLOOD (2001)
Consistent patterns of allelic loss in natural killer cell lymphoma
LLP Siu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
